Evidence map›Paper›PMID 35436499›Full record

ArticleJournal of lipid research2022

The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses.

Zack Saud, Victoria J Tyrrell, Andreas Zaragkoulias, Majd B Protty, Evelina Statkute, Anzelika Rubina, Kirsten Bentley, Daniel A White, Patricia Dos Santos Rodrigues, Robert C Murphy and 16 more

Open access · goldAbstract read
In one paragraph

Article in Journal of lipid research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 3 countries.

Zack SaudDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Victoria J TyrrellDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Andreas ZaragkouliasDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Majd B ProttyDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Evelina StatkuteDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Anzelika RubinaDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Kirsten BentleyDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Daniel A WhiteDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Patricia Dos Santos RodriguesDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Robert C MurphyDepartment of Pharmacology, University of Colorado Denver, Aurora, CO, USA.
Harald KöfelerCore Facility Mass Spectrometry, Medical University of Graz, Graz, Austria.
William J GriffithsMedical School, Swansea University, Swansea, United Kingdom.
Jorge Alvarez-JarretaDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Richard William BrownENT Department, Betsi Cadwaladr University Health Board, Wrexham Maelor Hospital, Wrexham, United Kingdom.
Robert G NewcombeDivision of Population Medicine, School of Medicine, Cardiff University, Cardiff, United Kingdom.
James HeymanDivision of Surgery, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
Manon PritchardAdvanced Therapies Group, School of Dentistry, Cardiff University, Cardiff, United Kingdom.
Robert Wj McleodDivision of Surgery, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
Arvind AryaENT Department, Betsi Cadwaladr University Health Board, Wrexham Maelor Hospital, Wrexham, United Kingdom.
Ceri-Ann LynchAnaesthetics and Critical Care Directorate, Cwm Taf University Health Board, Royal Glamorgan Hospital, Llantrisant, United Kingdom.
David OwensDivision of Surgery, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
P Vince JenkinsHaemostasis Diagnosis and Research, University Hospital Wales, Cardiff, United Kingdom.
Niklaas J BuurmaPhysical Organic Chemistry Centre, School of Chemistry, Cardiff University, Cardiff, United Kingdom.
Valerie B O'DonnellDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom. Electronic address: o-donnellvb@cardiff.ac.uk.
David W ThomasAdvanced Therapies Group, School of Dentistry, Cardiff University, Cardiff, United Kingdom. Electronic address: thomasdw2@cardiff.ac.uk.
Richard J StantonDivision of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom. Electronic address: StantonRJ@cardiff.ac.uk.
Cardiff University · GBCardiff and Vale University Health Board · GBBetsi Cadwaladr University Health Board · GBMedical University of Graz · ATRoyal Glamorgan Hospital · GBSwansea University · GBUniversity Hospital of Wales · GBUniversity of Colorado Denver · US

Funding

Medical Research Council MR/S00971X/1
6 · The paper itself

Abstract

The lipid envelope of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an essential component of the virus; however, its molecular composition is undetermined. Addressing this knowledge gap could support the design of antiviral agents as well as further our understanding of viral-host protein interactions, infectivity, pathogenicity, and innate immune system clearance. Lipidomics revealed that the virus envelope comprised mainly phospholipids (PLs), with some cholesterol and sphingolipids, and with cholesterol/phospholipid ratio similar to lysosomes. Unlike cellular membranes, procoagulant amino-PLs were present on the external side of the viral envelope at levels exceeding those on activated platelets. Accordingly, virions directly promoted blood coagulation. To investigate whether these differences could enable selective targeting of the viral envelope in vivo, we tested whether oral rinses containing lipid-disrupting chemicals could reduce infectivity. Products containing PL-disrupting surfactants (such as cetylpyridinium chloride) met European virucidal standards in vitro; however, components that altered the critical micelle concentration reduced efficacy, and products containing essential oils, povidone-iodine, or chlorhexidine were ineffective. This result was recapitulated in vivo, where a 30-s oral rinse with cetylpyridinium chloride mouthwash eliminated live virus in the oral cavity of patients with coronavirus disease 19 for at least 1 h, whereas povidone-iodine and saline mouthwashes were ineffective. We conclude that the SARS-CoV-2 lipid envelope i) is distinct from the host plasma membrane, which may enable design of selective antiviral approaches; ii) contains exposed phosphatidylethanolamine and phosphatidylserine, which may influence thrombosis, pathogenicity, and inflammation; and iii) can be selectively targeted in vivo by specific oral rinses.

Indexed as

COVID-19MouthwashesAntiviral AgentsCetylpyridiniumHumansLipidsPovidone-IodineRNA, ViralSARS-CoV-2Antiviral AgentsCetylpyridiniumLipidsMouthwashesPovidone-IodineRNA, Viralaminophospholipidscetylpyridinium chlorideclinical trialscoagulationCPCinflammationlipidomicsmouthwashphospholipidsvirology

Identifiers

PMID35436499
PMCPMC9010312
OpenAlexW4223979303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.